시리즈
제약/바이오/헬스케어
92제약/바이오/헬스케어 관련 보고서 모음입니다.
![인도의료시장, 갤럭시링, 봇핏 수혜주 - 드림텍](https://cdn.orangeboard.co.kr/images/reports/950a8ecf-4617-4f7c-a689-07f267c23414/image_214151212866559.png)
![](https://cdn.orangeboard.co.kr/images/profiles/950a8ecf-4617-4f7c-a689-07f267c23414/image_131353708714238.jpeg)
보유마진 72%
수익 -27%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![Bottom Fishing 6편 바이오다인](https://cdn.orangeboard.co.kr/images/reports/44bb7a5a-f08b-4412-ad03-baf02ee435fe/image_71940425542106.png)
무료
![30분 컷 재무제표 분석 2(feat 배당성향, 건강기능식품, 인건비 )](https://cdn.orangeboard.co.kr/images/reports/dac68f5b-dde0-4cd5-bfaa-f77ac142d95c/image_0554687222419.jpg)
무료
![[아이센스] 당뇨의 걱정이 커지는 만큼 회사도 커진다.](https://cdn.orangeboard.co.kr/images/reports/6276987b-0053-4ec1-9660-2b61c441d1eb/image_81452110453566.png)
![](https://cdn.orangeboard.co.kr/images/profiles/6276987b-0053-4ec1-9660-2b61c441d1eb/image_23811677567242.png)
보유마진 323%
수익 -33%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![[HK이노엔] 오른놈이 더 오를까?](https://cdn.orangeboard.co.kr/images/reports/412a62e7-d40d-4864-87b0-db3ef95743bb/image_12243721819936.png)
![](https://cdn.orangeboard.co.kr/images/profiles/412a62e7-d40d-4864-87b0-db3ef95743bb/image_123817909107077.jpeg)
보유마진 40%
수익 -5%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![JW생명과학, 수액제의 대표 메이커!](https://cdn.orangeboard.co.kr/images/reports/e67dbdcc-9901-460c-bbc3-9eb04181d07f/image_21292930596684.png)
![](https://cdn.orangeboard.co.kr/images/profiles/e67dbdcc-9901-460c-bbc3-9eb04181d07f/image_73024596392239.png)
보유마진 49%
수익 -7%
무료
![지아이이노베이션 무상증자 및 주가 전망 : 횡보를 끝내러 왔다](https://cdn.orangeboard.co.kr/images/reports/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_1724814263537.png)
![](https://cdn.orangeboard.co.kr/images/profiles/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_53939480706790.jpeg)
마진 52%
수익 0%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![위와 치아 이야기(feat 뮤신, 식도염, 위염, 침, 임플란트, 틀니)](https://cdn.orangeboard.co.kr/images/reports/dac68f5b-dde0-4cd5-bfaa-f77ac142d95c/image_087457068270.jpg)
무료
![다이어트 전쟁 근황(feat 비만치료제, 지방분해, 보톡스, 마운자로)](https://cdn.orangeboard.co.kr/images/reports/dac68f5b-dde0-4cd5-bfaa-f77ac142d95c/image_163940711379113.jpg)
무료
![코어라인소프트 주가 전망 :인공지능 의료 AI 관련주 저평가 주식](https://cdn.orangeboard.co.kr/images/reports/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_14461359794935.png)
![](https://cdn.orangeboard.co.kr/images/profiles/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_53939480706790.jpeg)
마진 57%
수익 -66%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![HLB 주가 전망 : 텐베거 종목](https://cdn.orangeboard.co.kr/images/reports/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_145536725673051.png)
![](https://cdn.orangeboard.co.kr/images/profiles/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_53939480706790.jpeg)
목표달성
수익 82%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![엔케이맥스 무상증자 및 주가 전망(현재 횡보 구간)](https://cdn.orangeboard.co.kr/images/reports/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_143845876289904.png)
![](https://cdn.orangeboard.co.kr/images/profiles/8eebcdb0-8257-4d2a-bd5a-3eba55cb29f5/image_53939480706790.jpeg)
마진 30%
수익 -69%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![뇌와 치매 이야기(feat 치매치료제, 레카네맙, 레켐비, 도나네맙)](https://cdn.orangeboard.co.kr/images/reports/dac68f5b-dde0-4cd5-bfaa-f77ac142d95c/image_235538206273905.jpg)
무료
![메르의 투자포인트 (feat. 제약/바이오, 아무나 이겨라)](https://cdn.orangeboard.co.kr/images/reports/7b6e143d-432a-4597-87ae-8eacd37015d3/image_21717839719904.png)
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![마이코플라즈마 폐렴 근황(feat 독감, 기침, 가래, 소아과 부족)](https://cdn.orangeboard.co.kr/images/reports/dac68f5b-dde0-4cd5-bfaa-f77ac142d95c/image_232012562073829.jpg)
무료
![녹십자, 면역글로불린 미국 진출](https://cdn.orangeboard.co.kr/images/reports/23674f12-088c-4f78-9312-4b2968a027f1/image_215241425938466.png)
![](https://cdn.orangeboard.co.kr/images/profiles/23674f12-088c-4f78-9312-4b2968a027f1/image_01936533001004.png)
마진 49%
최종 수익 5%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![CRISPR-Cas9 유전자가위 기술 근황](https://cdn.orangeboard.co.kr/images/reports/3a099001-0f8a-4fb5-8908-0f6db8b969ed/image_7053752925738.png)
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![유전자 가위 산업과 툴젠 기업분석](https://cdn.orangeboard.co.kr/images/reports/c976bf9a-804a-4994-a659-1cee91ba1fac/image_113611802814457.png)
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![제이브이엠 (feat. 국내 + 해외 모멘텀 + 4분기 최대 실적??)](https://cdn.orangeboard.co.kr/images/reports/d5580b3f-6a68-4a10-8057-a028f218b3be/image_13333824120628.png)
![](https://cdn.orangeboard.co.kr/images/profiles/d5580b3f-6a68-4a10-8057-a028f218b3be/image_91543932084066.jpg)
보유마진 31%
최종 수익 19%
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![글로벌 메가트랜드: 비만, 이차전지, 모빌리티](https://cdn.orangeboard.co.kr/images/reports/23674f12-088c-4f78-9312-4b2968a027f1/image_0155355638233.png)
![](https://cdn.orangeboard.co.kr/images/profiles/23674f12-088c-4f78-9312-4b2968a027f1/image_01936533001004.png)
보유
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![바이오/제약 라이선스 딜 전략 근황](https://cdn.orangeboard.co.kr/images/reports/3a099001-0f8a-4fb5-8908-0f6db8b969ed/image_211411634515216.png)
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![코어라인소프트 : 2D 의료AI는 진부해? 우리는 3D 의료AI!](https://cdn.orangeboard.co.kr/images/reports/12766ef8-aec5-4296-ad4a-55a45c7c5757/image_42654464481154.png)
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)
![보로노이, 암 덮인 허파마을 보로노이 나가신다.](https://cdn.orangeboard.co.kr/images/reports/ada195ac-37bf-4144-a2f3-2720391a14c7/image_141541189699528.png)
![](https://cdn.orangeboard.co.kr/images/profiles/ada195ac-37bf-4144-a2f3-2720391a14c7/image_14925900463803.jpg)
마진 128%
수익 66%
무료
![아델릭스 (티커 : ARDX) : First in class XPHOZAH fda 승인](https://cdn.orangeboard.co.kr/images/reports/abf68e07-6ad8-4951-97ef-5237e72b30f6/image_1040515333388.jpg)
![](https://cdn.orangeboard.co.kr/images/profiles/abf68e07-6ad8-4951-97ef-5237e72b30f6/image_52550670976510.png)
보유
![Orange Icon](https://orangeboard-front.s3.ap-northeast-2.amazonaws.com/public/images/point/orange_2x.png)